Results 91 to 97 of about 119,061 (97)

Targeted alpha therapy with bismuth-213 and actinium-225: Meeting future demand.

Journal of labelled compounds & radiopharmaceuticals, 2019
Targeted alpha therapy (TAT) is a promising approach for the treatment of cancer. The use of alpha emitters for cancer therapy has two distinct advantages over conventional therapies.
F. Bruchertseifer, Alban Kellerbauer, R. Malmbeck, A. Morgenstern   +3 more
semanticscholar   +1 more source

Activity and Adverse Events of Actinium-225-PSMA-617 in Advanced Metastatic Castration-resistant Prostate Cancer After Failure of Lutetium-177-PSMA.

European Urology, 2020
B. Feuerecker, R. Tauber, K. Knorr, M. Heck, A. Beheshti, C. Seidl, F. Bruchertseifer, A. Pickhard, A. Gafita, C. Kratochwil, M. Retz, J. Gschwend, W. Weber, C. D’Alessandria, A. Morgenstern, M. Eiber   +15 more
semanticscholar   +1 more source

Actinium-225-PSMA radioligand therapy of metastatic castration-resistant prostate cancer (WARMTH Act): a multicentre, retrospective study.

The Lancet Oncology
M. Sathekge, I. Lawal, C. Bal, F. Bruchertseifer, Sajana Ballal, Giuseppe Cardaci, Cindy Davis, Mathias Eiber, Turkay Hekimsoy, O. Knoesen, C. Kratochwil, N. Lenzo, Johncy Mahapane, Letjie C. Maserumule, A. Mdlophane, K. Mokoala, H. Ndlovu, Vineet Pant, H. Rathke, Janet Reed, I. Sen, Aviral Singh, A. Sood, R. Tauber, Parul Thakral, M. Yadav, A. Morgenstern   +26 more
semanticscholar   +1 more source

225 Improving the timeliness of discharge summaries in the acute admissions unit

225 Improving the timeliness of discharge summaries in the acute admissions unit
Rebecca Olubunmi Lawson, Dionne Matthew
semanticscholar   +1 more source

225 Cepstral and fourier based methods are feasible feature extraction approaches for parkinsons disease voice analysis

225 Cepstral and fourier based methods are feasible feature extraction approaches for parkinsons disease voice analysis
Davids Joseph, Grover Tim, Limousin Patricia, Foltyne Thomas, Hariz Marwan, Krueger Marie, Zrinzo Ludwic, Akram Harith   +7 more
semanticscholar   +1 more source

225 Ac-PSMA-617/ 177 Lu-PSMA-617 Tandem Therapy of Metastatic Castration-Resistant Prostate Cancer: Pilot Experience

Nuklearmedizin, 2019
Fadi Khreish, Niklas Ebert, M. Ries, S. Maus, F. Rosar, H. Bohnenberger, T. Stemler, M. Saar, M. Bartholomä, S. Ezziddin   +9 more
semanticscholar   +1 more source

99mTc‐MIP‐1404‐SPECT/CT for the detection of PSMA‐positive lesions in 225 patients with biochemical recurrence of prostate cancer

The Prostate, 2018
C. Schmidkonz, Claudia Hollweg, M. Beck, Julia Reinfelder, T. I. Goetz, J. Sanders, D. Schmidt, O. Prante, T. Bäuerle, A. Cavallaro, M. Uder, B. Wullich, P. Goebell, T. Kuwert, P. Ritt   +14 more
semanticscholar   +1 more source